These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12191565)

  • 1. Bcr-Abl variants: biological and clinical aspects.
    Advani AS; Pendergast AM
    Leuk Res; 2002 Aug; 26(8):713-20. PubMed ID: 12191565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia.
    Mian AA; Metodieva A; Najajreh Y; Ottmann OG; Mahajna J; Ruthardt M
    Haematologica; 2012 Feb; 97(2):251-7. PubMed ID: 22058195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations.
    Pane F; Intrieri M; Quintarelli C; Izzo B; Muccioli GC; Salvatore F
    Oncogene; 2002 Dec; 21(56):8652-67. PubMed ID: 12476311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.
    Guo JQ; Lian J; Glassman A; Talpaz M; Kantarjian H; Deisseroth AB; Arlinghaus RB
    Am J Clin Pathol; 1996 Oct; 106(4):442-8. PubMed ID: 8853030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bcr-abl gene in chronic myelogenous leukaemia.
    Sawyers CL
    Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
    J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 10. The BCR gene and philadelphia chromosome-positive leukemogenesis.
    Laurent E; Talpaz M; Kantarjian H; Kurzrock R
    Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
    [No Abstract]   [Full Text] [Related]  

  • 11. [The molecular biology diagnosis of neoplastic blood diseases].
    Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
    Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system].
    Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
    Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
    Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
    Randolph TR
    Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
    Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
    Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standpoint on imprinting of BCR and ABL.
    Fioretos T; Heisterkamp N; Groffen J
    Leukemia; 1995 Apr; 9(4):743-4. PubMed ID: 7723414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the 5' abl region in Philadelphia chromosome-positive chronic myeloid leukemia.
    Morel F; Ka C; Le Bris MJ; Herry A; Morice P; Bourquard P; Abgrall JF; Berthou C; De Braekeleer M
    Leukemia; 2003 Feb; 17(2):473-4. PubMed ID: 12592354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.